Hanna Schifter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hanna Schifter has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Barbara M. BrökEr
Institute of Immunology University Medicine Greifswald Greifswald Germany
1 shared publication - Ben Lewin Becker
Department of Medicine A University Medicine Greifswald Greifswald Germany
1 shared publication - Elke Hammer
Department of Functional Genomics, Interfaculty Institute of Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany
1 shared publication - Frank Ulrich Weiss
Department of Medicine A, University Medicine Greifswald, Greifswald, Germany
1 shared publication - Georg Homuth
Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany
1 shared publication Hala Mazloum
Department of Medicine A University Medicine Greifswald Greifswald Germany
1 shared publication
Latest Publications
- Open Access
- 3 September 2026
- Published by Wiley in Advanced Science
- Vol. 13 (64)
Interleukin‐1α Mediates Pancreatic Fibroblast Activation, Regulates Immune Cell Recruitment and Fibrosis in Acute and Chronic Pancreatitis
Pancreatitis is a life‐threatening inflammatory disease of the pancreas. The cytokine interleukin‐1α has been demonstrated to act as an alarmin released by necrotic cells. In the present study, we investigated the influence of IL‐1α on the immune response during acute and chronic pancreatitis. Following tissue injury, pancreatic acinar cells released IL‐1α, which activates tissue‐resident fibroblasts to differentiate toward a pro‐inflammatory phenotype. By secreting chemokines and cytokines such as CXCL5, CCL2, and IL‐6, these fibroblasts recruit immune cells to the pancreas. The absence of IL‐1α reduces disease severity in acute pancreatitis and chemokine release. Furthermore, IL‐1α primes fibroblasts to enhance the production of extracellular matrix‐components by the up‐regulation of pro‐fibrotic receptors such as Il4ra , Il13ra1 , and Tgfbr3 . Therefore, the deletion of IL‐1α significantly reduced the development of tissue fibrosis. A therapeutic blockade of the IL1R1‐signaling by i.p. administration of the IL‐1‐receptor antagonist Anakinra showed the same effect; the severity of acute pancreatitis and fibrogenesis during chronic pancreatitis were reduced. In conclusion, the crosstalk between necrotic acinar cells and fibroblasts mediated by IL‐1α plays a crucial role in acute inflammation of the pancreas and fibrogenic signaling. Blockade of IL1R1‐signaling by Anakinra is therefore a promising therapeutic intervention for both acute and chronic pancreatitis.
- 3 September 2026
- Published by Wiley in Advanced Science
- Vol. 13 (64)
Open AccessInterleukin‐1α Mediates Pancreatic Fibroblast Activation, Regulates Immune Cell Recruitment and Fibrosis in Acute and Chronic Pancreatitis
Pancreatitis is a life‐threatening inflammatory disease of the pancreas. The cytokine interleukin‐1α has been demonstrated to act as an alarmin released by necrotic cells. In the present study, we investigated the influence of IL‐1α on the immune response during acute and chronic pancreatitis. Following tissue injury, pancreatic acinar cells released IL‐1α, which activates tissue‐resident fibroblasts to differentiate toward a pro‐inflammatory phenotype. By secreting chemokines and cytokines such as CXCL5, CCL2, and IL‐6, these fibroblasts recruit immune cells to the pancreas. The absence of IL‐1α reduces disease severity in acute pancreatitis and chemokine release. Furthermore, IL‐1α primes fibroblasts to enhance the production of extracellular matrix‐components by the up‐regulation of pro‐fibrotic receptors such as Il4ra , Il13ra1 , and Tgfbr3 . Therefore, the deletion of IL‐1α significantly reduced the development of tissue fibrosis. A therapeutic blockade of the IL1R1‐signaling by i.p. administration of the IL‐1‐receptor antagonist Anakinra showed the same effect; the severity of acute pancreatitis and fibrogenesis during chronic pancreatitis were reduced. In conclusion, the crosstalk between necrotic acinar cells and fibroblasts mediated by IL‐1α plays a crucial role in acute inflammation of the pancreas and fibrogenic signaling. Blockade of IL1R1‐signaling by Anakinra is therefore a promising therapeutic intervention for both acute and chronic pancreatitis.